PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Joslin researchers find 'good fat' activated by cold, not ephedrine

Finding could help fight obesity epidemic

Joslin researchers find 'good fat' activated by cold, not ephedrine
2012-06-05
(Press-News.org) BOSTON -- June 4, 2012 -- Researchers at Joslin Diabetes Center have shown that while a type of "good" fat found in the body can be activated by cold temperatures, it is not able to be activated by the drug ephedrine.

The finding, published in today's issue of PNAS USA Early Edition, may lead to drugs or other methods aimed at activating the good fat, known as brown fat. When activated, brown fat burns calories and can help in the battle against obesity.

"We propose that agents that work similarly to cold in activating brown fat specifically can provide promising approaches to fighting obesity while minimizing other side effects," said Aaron Cypess, M.D., Ph.D., an assistant investigator and staff physician at Joslin and lead author of the paper.

"At the same time, we now know that ephedrine is not the way to do it," he added.

Brown fat is found in humans naturally and consumes calories to generate heat. Prior studies had shown that brown fat can be activated by cold exposure in a process called non-shivering thermogenesis.

Researchers have been working for years to find ways to activate brown fat.

Ephedrine, a decongestant and bronchodilator, has been used as a weight loss drug because it increases the number of calories burned. However, there are side effects.

In this study, the Joslin team tested 10 study subjects in three ways. They were each separately given injections of ephedrine, given injections of saline as a control, and made to wear "cooling vests" that had water cooled to 57 degrees pumped into them. After each intervention, the brown fat activity was measured using PET/CT scans.

The researchers found that brown fat activity was the same following both the ephedrine and saline injections. However, after the subjects wore the cooling vests for two hours, their brown fat activity was stimulated significantly.

Both interventions — ephedrine injections and the wearing of the cooling vests — did result in the same number of calories being burned, Dr. Cypess noted.

"But we found that ephedrine was not using brown fat to do it," he said. "This is the first time it has been found that ephedrine does not turn on brown fat."

Both interventions had other effects on the sympathetic nervous system -- which activates the fight or flight response -- such as increased blood pressure, but those associated with brown fat activation were fewer, the study showed.

"Mild cold exposure stimulates (brown fat) energy expenditure with fewer other systemic effects, suggesting that cold activates specific sympathetic pathways," the paper concludes. "Agents that mimic cold activation of (brown fat) could provide a promising approach to treating obesity while minimizing systemic effects."

As a result of the findings, drug companies may find it easier to come up with agents that stimulate brown fat to help people lose weight, Dr. Cypess said.

One method may be simply to design cooling vests that people can wear to help them lose weight. A future study will have subjects wear the vests for several weeks to see what happens, Dr. Cypess said.

"Will they get the same health benefits they would have seen with several weeks of exercise? That's the billion dollar question."

The findings should also be of interest to heart researchers interested in the mechanisms of activation of the sympathetic nervous system, he added.



INFORMATION:



Co-authors of today's study include Yih-Chieh Chen, Cathy Sze, Ke Wang, Jeffrey English, Onyee Chan, Ashley R. Holman, Ilan Tal, Matthew R. Palmer, Gerald M. Kolodny and C. Ronald Kahn. All are from either Joslin Diabetes Center or Beth Israel Deaconess Medical Center.

The study was funded by the National Institutes of Health.

About Joslin Diabetes Center

Joslin Diabetes Center, located in Boston, Massachusetts, is the world's largest diabetes research and clinical care organization. Joslin is dedicated to ensuring that people with diabetes live long, healthy lives and offers real hope and progress toward diabetes prevention and a cure. Joslin is an independent, nonprofit institution affiliated with Harvard Medical School.

Our mission is to prevent, treat and cure diabetes. Our vision is a world free of diabetes and its complications.

For more information, visit www.joslin.org.


[Attachments] See images for this press release:
Joslin researchers find 'good fat' activated by cold, not ephedrine

ELSE PRESS RELEASES FROM THIS DATE:

New statistical model lets patient's past forecast future ailments

2012-06-05
Analyzing medical records from thousands of patients, statisticians have devised a statistical model for predicting what other medical problems a patient might encounter. Like how Netflix recommends movies and TV shows or how Amazon.com suggests products to buy, the algorithm makes predictions based on what a patient has already experienced as well as the experiences of other patients showing a similar medical history. "This provides physicians with insights on what might be coming next for a patient, based on experiences of other patients. It also gives a predication ...

Hands-on research

2012-06-05
PASADENA, Calif.—A nuzzle of the neck, a stroke of the wrist, a brush of the knee—these caresses often signal a loving touch, but can also feel highly aversive, depending on who is delivering the touch, and to whom. Interested in how the brain makes connections between touch and emotion, neuroscientists at the California Institute of Technology (Caltech) have discovered that the association begins in the brain's primary somatosensory cortex, a region that, until now, was thought only to respond to basic touch, not to its emotional quality. The new finding is described ...

Drug combination highly effective for newly diagnosed myeloma patients

2012-06-05
A three-drug treatment for the blood cancer multiple myeloma provided rapid, deep and potentially durable responses, researchers report today online in Blood, the Journal of the American Society of Hematology, and yesterday, Sunday, June 3, 2012, at the American Society of Clinical Oncology's Annual Meeting in Chicago, IL, USA. The researchers, led by Andrzej J. Jakubowiak, M.D., Ph.D., professor of medicine and director of the multiple myeloma program at the University of Chicago Medical Center, found that combining carfilzomib, a next generation proteasome inhibitor, ...

Shape-shifting shell

Shape-shifting shell
2012-06-05
VIDEO: As a retrovirus matures, the two parts of its shell protein (red and blue or yellow and blue) dramatically rearrange themselves, twisting and moving away from each other. Click here for more information. Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, Germany, have for the first time uncovered the detailed structure of the shell that surrounds the genetic material of retroviruses, such as HIV, at a crucial and potentially vulnerable stage ...

Filming life in the fast lane

Filming life in the fast lane
2012-06-05
VIDEO: A fruit fly embryo from when it was about two-and-a-half hours old until it walked away from the microscope as a larva, filmed by a new microscope developed at EMBL.... Click here for more information. "This video shows a fruit fly embryo from when it was about two-and-a-half hours old until it walked away from the microscope as a larva, 20 hours later," says Lars Hufnagel, from the European Molecular Biology Laboratory (EMBL) in Heidelberg, Germany. "It shows all ...

Export extravaganza

Export extravaganza
2012-06-05
Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, Germany, have conducted the first comprehensive census of human cells' export workers. In a study published online today in Nature Cell Biology, they found an unexpected variety of genes involved in transporting molecules to the cell membrane and beyond. Using a combination of genetics and sophisticated microscopy, Rainer Pepperkok and colleagues systematically silenced each of our 22 000 genes, and observed to what extent this affected the cell's ability to transport a protein. They found that ...

From Paris Polyphenols to the IFT, HIDROX and CreAgri Receiving Continued Recognition

2012-06-05
Among the founding fathers of the biotechnology industry, Roberto Crea, PhD., founder and CEO of CreAgri Inc., is internationally acknowledged for the role he played in the successful establishment and growth of Genentech, Inc.--as one of the first four scientific founders of the legendary biotech company—and for his pioneering role in the production of many rDNA protein drugs from bacteria. Among other innovations, Dr. Crea is the inventor of the synthetic DNA process that led to the discovery of the first recombinant human insulin, Humulin , and many other pharmaceutical ...

A new multitarget molecule designed with high potential in future treatments for Alzheimer's disease

2012-06-05
Researchers at Universitat Autònoma de Barcelona (UAB), the Spanish National Research Council (CSIC) and the University of Barcelona (UB) have developed a multitarget molecule, ASS234, which according to the results of in vitro studies conducted, inhibits the aggregation of the ß-amyloid protein, involved in Alzheimer's disease. At the same time, ASS234 stimulates the cholinergic and monoaminergic transmission, key factors involved in the cognitive function. In addition, ASS234 is able to cross the blood–brain barrier with an elevated multipotent profile designed on basis ...

Hartzell Properties Announces Transformation of Shopping Center on Bethlehem Pike in Hatfield Pennsylvania

2012-06-05
A new facade rendering has already been drafted and in addition to a new beautiful exterior, the landlord is welcoming and friendly. Jack Intrator, Retail & Restaurant Leasing Specialist, explains, "You have all the necessary components to bring in a new and fresh tenant mix to a center that was dated at best." A crucial ingredient to a new tenant mix is a landlord that is committed to creating an asset for the future, not just looking at the bottom line of that specific day. This means you have a landlord that is prepared to invest in his tenancy, providing ...

A search engine for social networks based on the behavior of ants

A search engine for social networks based on the behavior of ants
2012-06-05
This press release is available in Spanish. VIDEO: Research at Carlos III University in Madrid is developing an algorithm, based on ants’ behavior when they are searching for food, which accelerates the search for relationships among elements that... Click here for more information. One of the main technical questions in the field of social networks, whose use is becoming more and ...

LAST 30 PRESS RELEASES:

Thirty-year mystery of dissonance in the “ringing” of black holes explained

Less intensive works best for agricultural soil

Arctic rivers project receives “national champion” designation from frontiers foundation

Computational biology paves the way for new ALS tests

Study offers new hope for babies born with opioid withdrawal syndrome

UT, Volkswagen Group of America celebrate research partnership

New Medicare program could dramatically improve affordability for cancer drugs – if patients enroll

Are ‘zombie’ skin cells harmful or helpful? The answer may be in their shapes

University of Cincinnati Cancer Center presents research at AACR 2025

Head and neck, breast, lung and survivorship studies headline Dana-Farber research at AACR Annual Meeting 2025

AACR: Researchers share promising results from MD Anderson clinical trials

New research explains why our waistlines expand in middle age

Advancements in muon detection: Taishan Antineutrino Observatory's innovative top veto tracker

Chips off the old block

Microvascular decompression combined with nerve combing for atypical trigeminal neuralgia

Cutting the complexity from digital carpentry

Lung immune cell type “quietly” controls inflammation in COVID-19

Fiscal impact of expanded Medicare coverage for GLP-1 receptor agonists to treat obesity

State and sociodemographic trends in US cigarette smoking with future projections

Young adults drive historic decline in smoking

NFCR congratulates Dr. Robert C. Bast, Jr. on receiving the AACR-Daniel D. Von Hoff Award for Outstanding Contributions to Education and Training in Cancer Research

Chimpanzee stem cells offer new insights into early embryonic development

This injected protein-like polymer helps tissues heal after a heart attack

FlexTech inaugural issue launches, pioneering interdisciplinary innovation in flexible technology

In Down syndrome mice, 40Hz light and sound improve cognition, neurogenesis, connectivity

Methyl eugenol: potential to inhibit oxidative stress, address related diseases, and its toxicological effects

A vascularized multilayer chip reveals shear stress-induced angiogenesis in diverse fluid conditions

AI helps unravel a cause of Alzheimer's disease and identify a therapeutic candidate

Coalition of Autism Scientists critiques US Department of Health and Human Services Autism Research Initiative

Structure dictates effectiveness, safety in nanomedicine

[Press-News.org] Joslin researchers find 'good fat' activated by cold, not ephedrine
Finding could help fight obesity epidemic